Cargando…
Spirocyclopiperazinium salt compound DXL-A-24 improves visceral sensation and gut microbiota in a rat model of irritable bowel syndrome
Irritable bowel syndrome (IBS) is characterized by visceral pain, impaired intestinal barrier and a disorder of the microbiota. DXL-A-24 has analgesic and anti-inflammatory effects by inhibiting neuropeptides and inflammatory factors. In this study, we used chronic unpredictable mild stress (CUMS) i...
Autores principales: | Xu, Yan, Yao, Ru, Zhao, Wenxue, Zhu, Jianguo, Yao, Jingchun, Zhang, Guimin, Liu, Dongguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250758/ https://www.ncbi.nlm.nih.gov/pubmed/37303540 http://dx.doi.org/10.1016/j.heliyon.2023.e16544 |
Ejemplares similares
-
Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome
por: Hasler, William L., et al.
Publicado: (2022) -
Stress-Related Alterations of Visceral Sensation: Animal Models for Irritable Bowel Syndrome Study
por: Larauche, Muriel, et al.
Publicado: (2011) -
A Choreography-Driven Approach to APIs: The OpenDXL Case Study
por: Frittelli, Leonardo, et al.
Publicado: (2020) -
A Pilot Study of the Effect of Daikenchuto on Rectal Sensation in Patients with Irritable Bowel Syndrome
por: Acosta, Andres, et al.
Publicado: (2016) -
Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases
por: Ceuleers, Hannah, et al.
Publicado: (2016)